Ventilator-associated Bacterial Pneumonia Clinical Trials

6 recruitingLast updated: May 29, 2026

There are 6 actively recruiting ventilator-associated bacterial pneumonia clinical trials across 14 countries. Studies span Phase 3, Phase 2, Phase 4. Top locations include Ampang, Selangor, Malaysia, Badajoz, Spain, Bangkok, Thailand. Updated daily from ClinicalTrials.gov.


Ventilator-associated Bacterial Pneumonia Trials at a Glance

6 actively recruiting trials for ventilator-associated bacterial pneumonia are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Phase 3 with 3 trials, with the heaviest enrollment activity in Ampang, Badajoz, and Bangkok. Lead sponsors running ventilator-associated bacterial pneumonia studies include Qilu Pharmaceutical Co., Ltd., BioVersys SAS, and Jiangsu HengRui Medicine Co., Ltd..

Browse ventilator-associated bacterial pneumonia trials by phase

Treatments under study

About Ventilator-associated Bacterial Pneumonia Clinical Trials

Looking for clinical trials for Ventilator-associated Bacterial Pneumonia? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ventilator-associated Bacterial Pneumonia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ventilator-associated Bacterial Pneumonia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Phase 3

Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex

Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)Colistin Resistanrt ABC+1 more
BioVersys SAS248 enrolled1 locationNCT07326540
Recruiting
Phase 2

A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex

Hospital-acquired Bacterial PneumoniaVentilator-associated Bacterial Pneumonia
Omnix Medical Ltd54 enrolled5 locationsNCT06087536
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP

Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia
Qilu Pharmaceutical Co., Ltd.420 enrolled1 locationNCT07327619
Recruiting
Phase 3

Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections

Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)Complicated Intra-abdominal Infection (cIAI)+2 more
Qilu Pharmaceutical Co., Ltd.80 enrolled1 locationNCT07089186
Recruiting
Phase 4

Optimising TREATment for Severe Gram-Negative Bacterial Infections

bloodstream infectionCarbapenem Resistant Bacterial InfectionMultidrug Resistance+2 more
National University of Singapore600 enrolled41 locationsNCT07004049
Recruiting
Phase 2

A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia

Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)
Jiangsu HengRui Medicine Co., Ltd.100 enrolled1 locationNCT06841731